UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Should Hemodynamic Guidance for Treatment of Acute Decompensated Heart Failure be Driven by the Right?

Journal of cardiac failure, 2018-01, Vol.24 (1), p.51-52

Franciosa, Joseph A.

2018

Volltextzugriff (PDF)

Acceptability and Psychometric Properties of the Minnesota Living With Heart Failure Questionnaire Among Patients Undergoing Heart Valve Surgery: Validation and Comparison With SF-36

Journal of cardiac failure, 2009-04, Vol.15 (3), p.267-277

2009

Volltextzugriff (PDF)

β-Blocker dosing in community-based treatment of heart failure

The American heart journal, 2007-06, Vol.153 (6), p.1029-1036

2007

Volltextzugriff (PDF)

Comparison of Outcomes and Usefulness of Carvedilol Across a Spectrum of Left Ventricular Ejection Fractions in Patients With Heart Failure in Clinical Practice

The American journal of cardiology, 2007-05, Vol.99 (9), p.1263-1268

2007

Volltextzugriff (PDF)

A Vasodilator Is a Vasodilator Is a Vasodilator?

Cardiology, 2015-01, Vol.130 (3), p.169-171

Franciosa, Joseph A.

2015

Volltextzugriff (PDF)

Evidence for the Continued Safety and Tolerability of Fixed-Dose Isosorbide Dinitrate/Hydralazine in Patients With Chronic Heart Failure (the Extension to African-American Heart Failure Trial)

The American journal of cardiology, 2007-08, Vol.100 (4), p.684-689

2007

Volltextzugriff (PDF)

Predictors of Clinical Outcomes in Patients Given Carvedilol for Heart Failure

The American journal of cardiology, 2006-12, Vol.98 (11), p.1480-1484

2006

Volltextzugriff (PDF)

Treatment of Heart Failure in African Americans: A Consensus Statement

Congestive heart failure (Greenwich, Conn.), 2010-01, Vol.16 (1), p.27-38

2010

Volltextzugriff (PDF)

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

The New England journal of medicine, 1986-06, Vol.314 (24), p.1547-1552

1986

Volltextzugriff (PDF)

The potential role of community-based registries to complement the limited applicability of clinical trial results to the community setting: heart failure as an example

The American journal of managed care, 2004-07, Vol.10 (7 Pt 2), p.487-492

Franciosa, Joseph A

2004

Volltextzugriff (PDF)

Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure

Expert opinion on pharmacotherapy, 2006-12, Vol.7 (18), p.2521-2531

Franciosa, Joseph A

2006

Volltextzugriff (PDF)

WOMEN HAVE GREATER MID-TERM QUALITY OF LIFE BENEFIT THAN MEN AFTER VALVULAR SURGERY

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E1363-E1363

2011

Volltextzugriff (PDF)

African-American Heart Failure Trial (A-HeFT): Rationale, design, and methodology

Journal of cardiac failure, 2002-06, Vol.8 (3), p.128-135

2002

Volltextzugriff (PDF)

β-blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registry

The American heart journal, 2004-10, Vol.148 (4), p.718-726

2004

Volltextzugriff (PDF)

Treatment of Heart Failure in African Americans: Executive Summary

Congestive heart failure (Greenwich, Conn.), 2010-01, Vol.16 (1), p.1-2

2010

Volltextzugriff (PDF)

Beta-adrenergic blocking agents: past, present, and future perspectives

Coronary artery disease, 1999-09, Vol.10 (6), p.369-376

Franciosa, J A

1999

Volltextzugriff (PDF)

Background and overview of a symposium to update the biology of atherosclerosis and its implications for treatment strategies

The American journal of cardiology, 2003-02, Vol.91 (3), p.1-2

2003

Volltextzugriff (PDF)

The African-American heart failure trial: Background, rationale and significance

Journal of the National Medical Association, 2002-09, Vol.94 (9), p.762-769

2002

Volltextzugriff (PDF)

Limitations of the use of clinical trial results in managing heart failure in the African-American community: A time for active participation in generating applicable data

Journal of the National Medical Association, 2003, Vol.95 (1), p.13-16

FRANCIOSA, Joseph A

2003

Volltextzugriff (PDF)

Tolerability, Safety, and Efficacy of β‐Blockade in Black Patients With Heart Failure in the Community Setting: Insights From a Large Prospective β‐Blocker Registry

Congestive heart failure (Greenwich, Conn.), 2007-01, Vol.13 (1), p.16-21

2007

Volltextzugriff (PDF)

Heart Failure in Community Practice: Relationship to Age and Sex in a β‐Blocker Registry

Congestive heart failure (Greenwich, Conn.), 2006-11, Vol.12 (6), p.317-323

2006

Volltextzugriff (PDF)

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure

The American journal of cardiology, 1981, Vol.47 (1), p.33-39

1981

Volltextzugriff (PDF)

Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure

The American journal of cardiology, 1984-09, Vol.54 (6), p.596-599

1984

Volltextzugriff (PDF)

Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure

JAMA : the journal of the American Medical Association, 1995-05, Vol.273 (18), p.1450

Garg, Rekha

1995

Volltextzugriff (PDF)

Exercise testing in chronic congestive heart failure

The American journal of cardiology, 1984-05, Vol.53 (10), p.1447-1450

Franciosa, Joseph A.

1984

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(132)

Erscheinungsjahr

n.n

Thema

Humans
(89)
Life Sciences & Biomedicine
(89)
Science & Technology
(89)
Cardiovascular System & Cardiology
(51)
Middle Aged
(49)
Male
(48)
Cardiac & Cardiovascular Systems
(47)
Heart Failure - Drug Therapy
(45)
Aged
(36)
Heart Failure - Physiopathology
(33)
General & Internal Medicine
(28)
Hemodynamics - Drug Effects
(26)
Medicine, General & Internal
(26)
Adult
(25)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Blood Pressure - Drug Effects
(20)
Female
(20)
Cardiac Output - Drug Effects
(17)
Vasodilator Agents - Therapeutic Use
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Should Hemodynamic Guidance for Treatment of Acute Decompensated Heart Failure be Driven by the Right?

Acceptability and Psychometric Properties of the Minnesota Living With Heart Failure Questionnaire Among Patients Undergoing Heart Valve Surgery: Validation and Comparison With SF-36

β-Blocker dosing in community-based treatment of heart failure

Comparison of Outcomes and Usefulness of Carvedilol Across a Spectrum of Left Ventricular Ejection Fractions in Patients With Heart Failure in Clinical Practice

A Vasodilator Is a Vasodilator Is a Vasodilator?

Evidence for the Continued Safety and Tolerability of Fixed-Dose Isosorbide Dinitrate/Hydralazine in Patients With Chronic Heart Failure (the Extension to African-American Heart Failure Trial)

Predictors of Clinical Outcomes in Patients Given Carvedilol for Heart Failure

Treatment of Heart Failure in African Americans: A Consensus Statement

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

The potential role of community-based registries to complement the limited applicability of clinical trial results to the community setting: heart failure as an example

Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure

WOMEN HAVE GREATER MID-TERM QUALITY OF LIFE BENEFIT THAN MEN AFTER VALVULAR SURGERY

African-American Heart Failure Trial (A-HeFT): Rationale, design, and methodology

β-blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registry

Treatment of Heart Failure in African Americans: Executive Summary

Beta-adrenergic blocking agents: past, present, and future perspectives

Background and overview of a symposium to update the biology of atherosclerosis and its implications for treatment strategies

The African-American heart failure trial: Background, rationale and significance

Limitations of the use of clinical trial results in managing heart failure in the African-American community: A time for active participation in generating applicable data

Tolerability, Safety, and Efficacy of β‐Blockade in Black Patients With Heart Failure in the Community Setting: Insights From a Large Prospective β‐Blocker Registry

Heart Failure in Community Practice: Relationship to Age and Sex in a β‐Blocker Registry

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure

Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure

Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure

Exercise testing in chronic congestive heart failure

Suchergebnisse filtern